Study S000548

Effect of the GLP-1 Receptor Agonist Exenatide on Impaired Hypoglycaemic Awareness in Type 1 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02735031
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2; PHASE3
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 10
Start: 2017-02-21
Primary completion: 2018-03-28
Lead sponsor: Radboud University Medical Center
Conditions: Diabetes Mellitus, Type 1; Hypoglycemia
Interventions: DRUG:Exenatide; DRUG:Placebo
Results posted: FALSE

Registered primary outcomes

Symptom score in response to insulin-induced hypoglycaemia [30 minutes]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.